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Neuronal differentiationTraumatic brain injury alters the signaling environment of the adult neurogenic niche and may activate unique
proliferative cell populations that contribute to the post-injury neurogenic response. Runx1 is not normally
expressed by adult neural stem or progenitor cells (NSPCs) but is induced in a subpopulation of putative
NSPCs after brain injury in adult mice. In order to investigate the role of Runx1 in NSPCs, we established
neurosphere cultures of adult mouse subventricular zone NSPCs. We show that Runx1 is basally expressed in
neurosphere culture. Removal of themitogen bFGF or addition of 1% FBS decreased Runx1 expression. Inhibition
of endogenous Runx1 activity with either Ro5-3335 or shRNA-mediated Runx1 knockdown inhibited NSPC pro-
liferationwithout affecting differentiation. Lentiviralmediated over-expression of Runx1 in neurospheres caused
a signiﬁcant change in cell morphology without reducing proliferation. Runx1-overexpressing neurospheres
changed from ﬂoating spheres to adherent colonies or individual unipolar or bipolar cells. Flow cytometry anal-
ysis indicated that Runx1 over-expression produced a signiﬁcant increase in expression of the neuronal marker
TuJ1 and a minor increase in the astrocytic marker S100β. Thus, Runx1 expression drove adult NSPC differentia-
tion, predominantly toward a neuronal lineage. These data suggest that Runx1 could bemanipulated after injury
to promote neuronal differentiation to facilitate repair of the CNS.
Published by Elsevier B.V.1. Introduction
Neural stem and progenitor cells (NSPCs) in the hippocampus and
subventricular zone are a constant source of new neurons in the adult
mammalian brain (Ming & Song, 2011). Following various types of
brain injuries, including traumatic brain injury, these NSPCs proliferate
and generate new neurons at an increased rate (Yu et al., 2008;
Enikolopov & Chen, 2009; Richardson et al., 2010; Zheng et al., 2013;
Chen et al., 2003; Chirumamilla et al., 2002; Sun et al., 2007). This inju-
ry-induced neurogenesis may contribute to post-injury maintenance
and recovery of cognitive ability (Blaiss et al., 2011), and to the repopu-
lation of neurons in damaged areas (Yu et al., 2008; Arvidsson et al.,
2002; Sohur et al., 2006). However, the regulatory signals that control
injury-induced neurogenesis and the stem cell population on which
they act are poorly understood.rmal growth factor; bFGF, basic
or cell; FBS, fetal bovine serum;
ction; DCX, doublecortin; SVZ,
acology, Uniformed Services
.Injury alters the signaling environment of the neurogenic niche
(Logan et al., 2013; Villapol et al., 2013) and may also activate unique
proliferative cell populations that contribute to the post-injury neuro-
genic response (Lopez-Juarez et al., 2013). However, the changes in
composition of the heterogeneous cell populationwithin the neurogen-
ic niches of the adult brain with injury are not well understood. We re-
cently found that expression of the transcription factor Runx1 is
induced in a subpopulation of proliferative putative adult NSPCs in the
SVZ (subventricular zone) and dentate gyrus after traumatic brain inju-
ry in adult mouse brain, areas where Runx1 is not normally expressed
(Logan et al., 2013). The function of Runx1 induction post-injury in
the neurogenic niche is not known.
Runx1 was originally identiﬁed in cases of acute myeloid leukemia,
where Runx1 chromosomal fusions lead to acute leukemia (Miyoshi et
al., 1991; Ito, 2008). Subsequently, Runx1 was found to be essential
for deﬁnitive hematopoiesis, regulating the transcription of several crit-
ical genes for hematopoietic development (Friedman, 2009). In hema-
topoietic stem cells (HSCs), over-expression of full-length Runx1
causes murine HSCs to exit the cell cycle and become quiescent, where-
as over-expression of an endogenous truncated dominant negative
Runx1 (Runx1a) leads to increased proliferation (Tsuzuki et al., 2007;
Challen &Goodell, 2010). In numerous other cell types, Runx1 regulates
cell proliferation, sometimes promoting, and sometimes inhibiting, cell
division (Friedman, 2009; Scheitz & Tumbar, 2013; Blyth et al., 2005;
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protein. Runx1 stability and DNA binding is enhanced approximately
ten-fold through complexing with the protein, CBFβ (Bravo et al.,
2001; Tang et al., 2000a; Tang et al., 2000b). Both proteins are necessary
for normal Runx1 function in vivo, as demonstrated by the similar phe-
notype of mice that are null for either Runx1 or CBFβ (Wang et al.,
1996).
Runx1 also controls the proliferation and neuronal differentiation of
certain neural progenitor cell populations. In embryonic olfactory bulb
progenitor cells in vivo, as well as in cultures of either embryonic olfac-
tory progenitor cells or embryonic cortical NSPCs, Runx1 increases cell
proliferation and also increases the expression of the neuronal marker
protein NeuroD (Theriault et al., 2005). However, Runx1 inhibits the
proliferation of embryonic microglia (Zusso, 2012) and olfactory
ensheathing cells (Murthy et al., 2014). Given its ability to regulate
stem and progenitor cell proliferation and differentiation, induction of
Runx1 in some NSPCs after injury (Logan et al., 2013) suggests that
Runx1 could be regulating the injury-induced proliferation or neuronal
differentiation of a speciﬁc subpopulation of adult NSPCs.
We therefore investigated the expression and function of Runx1 in
adult NSPCs, using neurosphere cultures of adult mouse NSPCs. We
demonstrate that Runx1 is expressed in adult neurosphere cultures,
and expression decreases in different culture conditions. We found
that inhibiting Runx1 activity can inhibit adult NSPC proliferation, and
that induction of Runx1 through lentiviral mediated over-expression
pushes NSPCs predominantly toward a neuronal lineage. Thus, Runx1
may play an important role in the injury-induced neurogenesis seen
in the adult mammalian brain after models of traumatic brain injury.
2. Materials and methods
2.1. Adult neurosphere cultures
All animal care and procedures were approved by the Institutional
Animal Care and Use Committee at Uniformed Services University and
performed in accordance with their guidelines. Adult male C57BL/6
mice (NCI, Frederick, MD), approximately 9 weeks of age, were deeply
anesthetized by isoﬂurane inhalation and euthanized by decapitation.
Brains were excised, placed in ice-cold PBS, and the tissue adjacent to
the anterior portion of the lateral ventricles containing the SVZ carefully
dissected out. This tissue was homogenized (Miltenyi neural tissue dis-
sociation kit, Miltenyi Biotec, MA), passed through a 70 μM ﬁlter to ob-
tain a single cell suspension, and plated in Neurocult complete culture
media (Stem Cell Technologies, WA, 05702) supplemented with
20 ng/mL EGF, 20 ng/mL bFGF, and 2 μg/mL heparin (‘growth’ media).
These primary cultures were grown initially for 7 days. Cells were
then passaged every 5 days for subsequent passage numbers. Cells
from passages 3–5 were used for all experiments. For treatment of
neurosphere cultures with the Runx1 inhibitor Ro5-3335 (Calbiochem,
MA, no. 219506), Ro5-3335 was resuspended at 250 mM in DMSO, and
further diluted in sterile PBS for treatments. The highest concentration
of inhibitor resulted in a 0.01% DMSO concentration. Thus, 0.01%
DMSO was used as a control. For treatment with Ro5-3335, cells were
plated at a density of 6 × 105 cells/100mmdish. For lentiviral transduc-
tion experiments, cells were plated in 48well culture dishes at a density
of 2000 cells/well.
2.2. Lentivirus generation and treatment
Lentiviral plasmids pLenti-suCMV(Runx1)-Rsv(GFP-Bsd) (termed
LV-Runx1) and LV-PL3 (LV-RSV(GFP-Bsd) (termed LV-GFP)) were pur-
chased from GenTarget inc (Gentarget, CA). Runx1 silencing shRNA
lentiviral plasmids (GIPZ Mouse Runx1 shRNA) with clone IDs:
V2LMM_70199, V3LMM_506997, V3LMM_506996, V3LMM_521271,
and GIPZ non-silencing lentiviral shRNA control (RHS4348) were pur-
chased from Thermo-Scientiﬁc (Pittsburgh, PA). Lentiviral plasmidsfrom Gentarget, packaged with VSVG and delta 8.2 plasmids, and GIPZ
Runx1 silencing and non-silencing lentiviral plasmids packaged with
psPAX2 and pMD2.G plasmids were transfected into HEK 293 T cells
with lipofectamine in DMEM/10%FBS. 12 h after transfection, the
mediawas discarded and replaced by serum-freemedia.Media contain-
ing viral particles was collected every 12 h, up to 36 hwith fresh serum-
free media added to the cells after each collection. Viral containing
media was stored at 4 °C until 3 sets of media were collected. Combined
viral containingmediawas centrifuged at low speed to clear large debris
and ﬁltered through a 0.45 μM ﬁlter. The virus particles were then con-
centrated by ultracentrifugation at 25,000 rpm in a Beckman SW27
rotor for 2 h, and resuspended in sterile PBS. Viral titer was determined
by analysis of GFP expression in HEK 293 T transduced cells, 72 h after
viral transduction by ﬂow cytometry. Neurosphere cultures were trans-
duced by lentiviral particles at an MOI of 10, 1 day after passaging.
2.3. Protein extraction and Western blots
Neurosphereswere grown inmedia containing the indicated growth
factors for 24 h before harvest. Both ﬂoating neurospheres and loosely
adherent cells were collected, pelleted by low-speed spin at 4 °C,
washed with ice-cold PBS, and resuspended in 1% RIPA lysis buffer con-
taining protease and phosphatase inhibitors. Cells were lysed before
centrifugation at 1600 g, at 4 °C for 20 min. Protein concentration in
the supernatantwasdetermined by theBCAprotein assay (Pierce, Rock-
ford, IL, USA). 15 μg protein was combined with loading buffer, boiled
for 5 min, before loading onto an SDS–polyacrylamide gel. Separated
proteins were transferred onto nitrocellulose membranes and probed
with rabbit anti-Runx1 antisera (1:1000, Novus, no. NBP1-89105), or
rabbit anti-β-actin (1:8000, Sigma, no. A1978), followed by incubation
with goat anti-rabbit IgG HRP-linked secondary antibody (Cell Signal-
ing, MA). Blots were developedwith supersignal-enhanced chemilumi-
nescence reagent (Thermo-Scientiﬁc) and detected using a Fuji LAS-
3000 image acquisition system (Fuji, Stamford, CT, USA) equipped
with a cooled CCD camera. For each experiment, blots were ﬁrst probed
with the Runx1 antiserum, before being stripped and reprobed for β-
actin. Runx1 expression was normalized to the expression level of β-
actin.
2.4. RNA isolation and qPCR
Cells were harvested, washedwith ice-cold PBS, and resuspended in
TRIzol reagent (Invitrogen, CA). 0.2 volumes of chloroformwere added,
tubes were centrifuged at 16,000 g for 15 min, and the aqueous layer
was extracted for RNA isolation. Further puriﬁcation proceeded with
the RNeasy mini kit (Qiagen, MD). Isolated RNA was then incubated
with RNase-free DNase according to the manufacturer's instructions
and quantiﬁedwith a Nanodrop spectrophotometer (Thermo Scientiﬁc,
DE). RNA integrity was checked by agarose gel electrophoresis. qPCR
was performed with SYBR Green qPCR MasterMix (Qiagen, CA) using
the BioRad CFX96 instrument and the following gene-speciﬁc primers:
Runx1; forward 5′TGGCACTCTGGTCACCGTCAT3′, reverse 5′GAAGCTCT
TGCCTCTACCGC3′, cyclin D1; forward 5′AGAGGGCTGTCGGCGCAGTA3′,
reverse 5′GGCTGTGGTCTCGGTTGGGC3′, p21; forward 5′TCCAGGAGG
CCCGAGAACGG3′, reverse 5′CTCCGAACGCGCTCCCAGAC3′. GAPDH; for-
ward 5′ACCATCTTCCAGGAGCGAGA3′, reverse 5′GGCGGAGATGATGA
CCCT3′. Reactions consisted of 10min incubation at 95 °C, then 40 cycles
of denaturation at 95 °C for 15 s and annealing/elongation at 58 °C for
10 s. Expression levels of all genes of interest were normalized to
GAPDH, and relative changes in gene expression were calculated using
the delta delta threshold cycle method (Susarla et al., 2011).
2.5. Cell culture imaging and quantiﬁcations
Neurospheres were treated 24 h following passage with either dif-
ferent concentrations of Ro5-3335 or lentiviral particles. Cells were
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rants by marking the cap, and an experimenter blind to the treatment
conditions randomly captured one image from each quadrant and one
from the center of the plate. The image ﬁelds captured covered roughly
a 3.75mm2 area, and imageswere analyzedwith ImageJ software (NIH)
to quantify the number of neurospheres, adherent colonies, and mor-
phologically differentiated cells in each image, as well as to measure
the average diameter of the neurospheres. In each experiment, at least
three culture disheswere treated for each condition, andmeasurements
from each of the dishes were averaged. Each experimentwas replicated
3 times.
2.6. Cell harvest and processing for ﬂow cytometry and cell survival
analyses
Cells were treated as described, and on the ﬁfth treatment day, cells
were harvested andwashed in ice-cold PBS, pelleted again, and incubat-
ed with 0.025% trypsin with EDTA in PBS at 37 °C for 10 min. 4 mL of
growth media was added and cells were triturated to obtain a single
cell suspension. Cells were then pelleted and resuspended in 2 mL
PBS, and passed through a 70 μM ﬁlter to obtain single cell suspension
prior to further processing.
2.7. Analysis of proliferation
Cells were treated as indicated for 5 days. On the ﬁfth day, EdU was
added (ﬁnal concentration 10 μM), and either 7 h (with Ro5-3555) or
5 h (with shRNA) later the cells were harvested. Cells were then ﬁxed
and processed using the Click-IT ﬂow cytometry assay kit (Invitrogen,
CA, no. C10424) with EdU covalently bound to an Alexa Fluor 647-
coupled ﬂuorescent molecule. EdU incorporation was visualized using
a BDAccuri C6ﬂow cytometer and CFlowplus software (BD biosciences,
CA). Events were gated for cells based on forward and side scatter pa-
rameters to exclude cell debris or clusters. When neurospheres were
transduced with GIPZ lentiviral particles, cells were also gated for GFP
expression before determining EdU incorporation. A minimum of
10,000 gated cells were quantiﬁed for each condition.
2.8. Cell survival analysis
Cells were treated in duplicate with the indicated concentrations of
Ro5-3335. On the ﬁfth day, cells were harvested as described, and for
each sample, a 10 μL aliquot of cell solution in PBS was removed and
combined with equal volume of trypan blue solution (0.4%, BioRad,
CA). The percentages of cells excluding the dye in each sample were de-
termined using a Biorad TC10 automated cell counter (BioRad, CA).
2.9. Flow cytometry for differentiation markers
Cells were harvested, ﬁxed, and permeabilized for intracellular anti-
gen staining using the FoxP3/Transcription Factor Staining Buffer set
(eBioscience, CA, no. 00-5523), following manufacturer's protocols.
Cells were stained with the primary antibodies: mouse anti-Tuj1
(1:12.5, Promega, WI, no. G712A), mouse anti-GFAP (1:50, Millipore,
MA, no. MAB360), mouse anti-S100β (1:50 Sigma–Aldrich, MO, no.
S2532), or guinea pig anti-doublecortin (1:100 Milllipore, no. AB2253)
followed by secondary antibody staining with goat anti-mouse
AlexaFluor 405 (1:1000 Invitrogen, CA, no. A31553) or goat anti-guinea
pig AlexaFluor 647 (1:1000 Invitrogen, no. A21450). Cell counts were
quantiﬁed using a BD LSR II ﬂow cytometer (BD biosciences, CA). Events
were gated for cells based on forward and side scatter parameters to ex-
clude cell debris or clusters. A minimum of 6000 cell events were quan-
tiﬁed for each measurement. Population analyses were then performed
using FlowJo software (TreeStar Inc., OR).2.10. Statistical analysis
All experiments presented were performed a minimum of 3 times
on independent neurosphere cultures. All data in this study are
expressed as mean± S.E.M. p b 0.05 was considered statistically signif-
icant. Intergroup differences were evaluated by one-way ANOVA
followed by Dunnett or Holms-Sidak multiple comparison correction.
Repeated measures one-way ANOVA were performed with data from
neurosphere cultures treatedwithRo5-3335 followedbyDunnettsmul-
tiple comparison correction. All statistics were performed with Prism 6
software (GraphPad, San Diego, CA).
3. Results
3.1. Adult neurospheres express Runx1 protein at highest levels in growth-
promoting conditions
Runx1 was expressed in adult mouse neurospheres cultured in typ-
ical growthmedia containing epidermal growth factor (EGF), a required
trophic andmitogenic factor (Reynolds &Weiss, 1992), and basic ﬁbro-
blast growth factor (bFGF, FGF2), also a potent mitogen (Kuhn et al.,
1997; Vescovi et al., 1993; Wagner et al., 1999; Gil-Perotin et al.,
2013) (Fig. 1A). Removing bFGF from themedia reduced Runx1 expres-
sion, and addition of 1% fetal bovine serum (FBS) reduced Runx1 ex-
pression further (Fig. 1A, C). Removal of bFGF resulted in smaller
neurospheres without any change in morphology (Fig. 1D). As previ-
ously described, addition of 1% FBS resulted in NSPC differentiation pri-
marily into astrocytes (Fig. 1D) (Bonnert et al., 2006). We did not,
however, detect any signiﬁcant change in Runx1 mRNA expression in
these different culture conditions suggesting that Runx1 regulation
was post-transcriptional (Fig. 1B).
3.2. Inhibition of Runx1 transcriptional activity inhibits neurosphere
growth
The compound Ro5-3335 is a potent inhibitor of the interaction be-
tween Runx1 and its partner protein CBFβ (Cunningham et al., 2012)
and inhibits Runx1-mediated transcriptional regulation though Runx1
remains able to bind DNA (Cunningham et al., 2012). To examine the
function of Runx1-mediated transcription in neurospheres, we treated
neurospheres cultured in growth media (containing EGF and bFGF)
with increasing concentrations of Ro5-3335 for 5 days. The size of the
neurospheres formed decreased signiﬁcantly when cultured in 5 or
25 μMRo5-3335without a decrease in the total number of neurospheres
(Fig. 2A, B). 5 μM and 25 μM Ro5-3335 were reported to reduce Runx1-
driven luciferase reporter activity by approximately 10% and50%, respec-
tively (Cunningham et al., 2012). Thus inhibition of Runx1 activity led to
a decrease in the overall proliferation rate or proliferative fraction of the
NSPCs within the neurosphere.
To more directly determinewhether inhibition of Runx1 activity led
to a decrease in the rate of proliferation, we determined the amount of
incorporation of EdU (a thymidine analog) into DNA by neurosphere
cells after a 5 day treatment with different concentrations of Ro5-3335
(Fig. 3A, B). After a 7 h pulse of EdU, cells were ﬁxed, processed, and an-
alyzed by ﬂow cytometry. Ro5-3335 inhibitor treatment reduced the
percentage of cellswithin neurospheres that incorporated EdU from ap-
proximately 40% in control media to 30% after treatment with 25 μM
Ro5-3335 (Fig. 3A). This corresponds to an approximately 25% decrease
in the percentage of cells which incorporated EdU. The amount of EdU
incorporated into cells also dropped, with a 50% decrease in the mean
ﬂuorescence intensity of the EdU signal, in cells treated with 25 μM
Ro5-3335 compared to control cells (Fig. 3B). Cell survival was not al-
tered by treatment with any concentration of Ro5-3335 for 5 days
(Fig. 3C, n = 2). Thus, inhibition of Runx1 activity with Ro5-3335 led
to a reduction in the overall proliferation of neurosphere cultures.
Fig. 1.Neurosphere Runx1 protein expression drops in the absence of bFGF or the presence of 1% FBS. A)Quantiﬁcation ofWestern blots of Runx1 expression in neurospheres grown in different
medias for 24 h, normalized to the expression ofβ-actin. (mean± s.e.m., n=6, *p b 0.05, ***p b 0.001). B) QPCR analysis of Runx1mRNA expression in neurospheres cultured in indicated
media for 24 h. Runx1 mRNA was normalized to GAPDHmRNA, (mean ± s.e.m., n = 3). C) Typical Western blot of Runx1 and β-actin expression in neurospheres with different culture
conditions. D) Bright ﬁeld images of neurospheres after 1 or 5 days in vitro (DIV) cultured with the indicated growth factors or serum. Scale bar—50 μm.
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encoding the cell cycle regulators p21 (CDKN1A) and cyclin D1
(CCND1) approximately 2-fold after a 5 day treatment (Fig. 3D, 3E). Ex-
pression of the gene encoding cdk2 was not altered by Ro5-3335 treat-
ment (data not shown). Although both CDKN1A and CCND1 are direct
targets of Runx1 gene transcriptional regulation in different cell types
(Theriault et al., 2005; Robertson et al., 2008), Runx1 regulation of p21
and cyclin D1 varies with context. Further work directed at elucidating
how Runx1 regulates p21 and cyclin D1 expression in neurospheres
will be required to understand the relationship between the anti-prolif-
erative effect of Ro5-3335 and its effects on these cell cycle regulators.
To conﬁrm that a reduction in Runx1 activity led to a decrease in
proliferation of neurospheres, we used lentiviral expressed shRNA
against Runx1. Four different Runx1 shRNA silencing viruses (pGIPZ
lentiviral vector, Dharmacon, Lafayette, CO) together with a non-silencing control were produced, concentrated, and tested to determine
the sequence that produced the greatest knockdown of endogenous
Runx1 expression. Transduction of one construct (V3LMM_521271-
LVshRunx1) reduced Runx1 expression by approximately 30% in
neurosphere cultures (Fig. 4A) in comparison to Runx1 expression in
cells transduced with the non-silencing control (LV-shNScontrol). We
transduced neurospheres with either LV-ShRunx1 or LV-shNScontrol
and 3 days later incubated cells with EdU for 5 h to determine the per-
centage of cells that were proliferating. As these lentiviral constructs
expressed turboGFP, we gated cells for GFP expression, before analysis
of EdU incorporation to ensure analysis of virally transduced cells.
Knockdown of Runx1 expression in neurospheres reduced the number
of cells incorporating EdU by 15% in comparison to neurospheres trans-
duced with the LV-shNScontrol (Fig. 4B). In virally transduced cells, ap-
proximately 65% of cells incorporated EdU in the LV-shNScontrol-
Fig. 2. Ro5-3335 inhibitor treatments decrease neurosphere diameter. A) Different concentrations of Ro5-3335 did not signiﬁcantly alter the number of ﬂoating multicellular neurospheres
formed over 5 days in growthmedia. B) The average diameter of neurosphereswas changed, decreasing at 5 (p b 0.001) and 25 μM(p b 0.001) Ro5-3555 (mean± s.e.m., n= 3). C) Bright
ﬁeld images of the cells after 5 days in the indicated concentrations of Runx1 inhibitor. Scale bar—100 μm.
Fig. 3. Ro5-3335 inhibitor treatment decreases neurosphere EdU incorporation and induces expression of p21 and cyclin D1 without increasing cell death. A) EdU was pulsed for 7 h in
neurosphere cultures treatedwith the indicated concentrations of Ro5-3335 for 5 days and quantiﬁed by ﬂow cytometry. The total percentage of cells incorporating EdUwas signiﬁcantly
altered by 25 μM Ro5-3335 (mean ± s.e.m., n = 3, *p b 0.05). B) The mean ﬂuorescence intensity of EdU signal was also decreased by approximately half on treatment with 25 μM and
50 μMRo5-3335, (mean± s.e.m., n= 3, **p b 0.01, ***p b 0.001). C) The level of trypan blue exclusion (±SEM) by the cells was unchanged at any Ro5-3335 concentrations, indicating no
increase in cell death by Ro5-3335. D and E) QPCR analysis of expression of p21 and cyclin D1mRNA, showed increased expression or p21with 50 μMRo5-3335 and cyclin D1with 5, 25,
and 50 μM Ro5-3335 (mean ± s.e.m., n = 5 *p b 0.05, **p b 0.01).
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Fig. 4.Runx1 knockdownwith lentiviral shRNA reduced neurosphere proliferation. A) Runx1 expression in lysates fromneurospheres transducedwith either the non-silencing LV control (LV-
shNScontrol), LV Runx1 shRNA (LVshRunx1) or control, non-transduced cells. LVshRunx1-transduced neurospheres reduced Runx1 expression by approximately 30%. B) Neurosphere
cultures were transduced with either LV-shNScontrol or LVshRunx1 for 4 days before a 5 h EdU pulse and analysis of EdU incorporation. Data are gated for GFP expression and expressed
as a percentage of EdU-positive cells in cells transduced with LV-shNScontrol (mean ± s.e.m., n = 3). EdU incorporation was signiﬁcantly decreased (*p b 0.05) by LVshRunx1. C) Bright
ﬁeld phase contrast images (phase) and green ﬂuorescent images (GFP) of neurospheres after 4 days in vitro (3 days after lentiviral transduction with either LV-shNScontrol or
LVshRunx1) showing smaller spheres in the presence of LVshRunx1. Scale bar—50 μm.
559T.T. Logan et al. / Stem Cell Research 15 (2015) 554–564tranduced cells, in comparison to 55% of cells transduced with LV-
shRunx1. Neurospheres transduced with LVshRunx1 were smaller
than those transduced with LV-shNScontrol, despite approximately
equal transduction efﬁciencies (Fig. 4C). Collectively, these data show
that knockdown of Runx1 reduced the number of dividing cells.
3.3. Runx1 over-expression induces morphological differentiation of
neurosphere cells
To determine the function of Runx1 in neurospheres, we developed
a lentiviral over-expression system for Runx1. Human Runx1b was
expressed under the control of a modiﬁed high-activity CMV promoter
(suCMV), in the same plasmid as RSV-GFP, in order to visualize trans-
duced cells (LV-Runx1). Human Runx1b is most homologous to murine
Runx1 isoform 3 (supplemental ﬁgure 1), an isoform that was actively
expressed in our neurosphere cultures (supplemental ﬁgure 1). The
control lentiviral vector expressed only GFP under the identical RSV
promoter in the same plasmid backbone (LV-GFP).
Neurospheres transduced with lentiviral particles containing LV-
Runx1 showed a dramatic change in morphology (Fig. 5). Treatment
with LV-Runx1 induced the majority of cells to form colonies of adher-
ent, irregularly shaped cell aggregates or to dissociate to individual ad-
herent cells (Fig. 5aiii, aiv C, D). These adherent cells typically bore a
small cell body with one or two long thin processes, often terminating
in slightly bulbed end feet, reminiscent of the leading process of migra-
tory neuroblasts. These cells could be seen growing alone and alsowith-
in the cell clusters (Fig. 5aiii, aiv, av). Transduction with the control
lentivirus, LV-GFP, had no effect on neurosphere morphology as
the control-transduced neurospheres grew similar to PBS-treated
neurospheres, with spherical, ﬂoating colonies of small spherical cells
with almost no adherent cells detected (Fig. 5ai, aii, C, D). Quantiﬁcation
of neurospheres and adherent cells revealed an almost completemutual
exclusion between the number of ﬂoating neurospheres and thenumber of adherent aggregates (Fig. 5C, D), with the total number of
these cell aggregates remaining constant between treatment groups
(Fig. 5F). Thus, LV-Runx1 transduction resulted in a dramatic decrease
in the density of ﬂoating neurospheres and a signiﬁcant increase in
the number of adherent aggregate cell formations counted (Fig. 5C,D).
The similarity in the total number of ﬂoating and adherent aggre-
gates between LV-Runx1 and LV-GFP treatments suggested that there
may be no change in the proliferation rate under these different condi-
tions, despite dramatically different morphologies. We therefore deter-
mined the amount of EdU incorporated into lentiviral transduced
neurosphere cultures. There was no difference in the percentage of
cells incorporating EdU, either in all cells in the culture (Fig. 5G), or spe-
ciﬁcally in lentivirally transduced GFP+ cells between cells transduced
with LV-Runx1 or LV-GFP (Fig. 5H). Thus, over-expression of Runx1 in-
duced a clear morphological change in many of the cells, but did not
alter their proliferative capacity.
3.4. Runx1 over-expression induces the expression of primarily neuronal
lineage markers
To determine whether the morphological change after Runx1 over-
expression was a result of a change in the differentiation of the NSPCs,
we examined expression of cell-speciﬁc markers for neurons and astro-
cytes. As LV-GFP transduced cells consistently exhibited nomorpholog-
ical differences from untreated control cells, these free-ﬂoating
neurospheres were impossible to quantitate thoroughly by standard
immunostaining techniques in our hands. We therefore employed
ﬂow cytometry analysis to quantify the percentages of cells transduced
by either LV-GFP or LV-Runx1 that expressed various markers of differ-
entiated cells (Fig. 6). Over-expression of Runx1 in LV-Runx1-trans-
duced cells increased the percentage of cells expressing doublecortin
(DCX), a marker of immature neuroblasts from 20.3% in the control
LV-GFP-transduced cells to 27.3% (Fig. 6A). Runx1 over-expression
Fig. 5. Runx1 over-expression induces adherence and morphological differentiation of neurospheres, without affecting proliferation. A) Bright ﬁeld images and B) their corresponding GFP-
ﬂuorescent images of neurospheres in growthmedia treatedwith PBS, LV-GFP, or LV-Runx1. Quantiﬁcation shows C) that the formation of ﬂoating neurospheres over the course of 5 days
in growth media was greatly reduced by transduction with LV-Runx1 (p N 0.01), while D) the formation of adherent cell aggregates was increased (p N 0.001), and E) the formation of
morphologically differentiated, individual, adherent, process-bearing cells appeared after LV-Runx1 transduction (p N 0.05). F) The total number of cell aggregates, either as ﬂoating
neurospheres or adherent colonies, was unchanged by either lentiviral treatment (n= 3). EdU incorporation over a 7-h pulse, 5 days after lentiviral treatment, was not changed by either
treatment, as quantiﬁed by ﬂow cytometry, either in the total cell population (G), nor speciﬁcally in GFP+ lentiviral transfected cells (H) (n = 2). ai–aiii scale bar—100 μm; aiv, scale
bar—25 μm; av., scale bar—50 μm. Error bars in graphs C–F indicate SEM. Error bars in G, H indicate SD.
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pressing high levels of Tuj1, (also called ßIII-tubulin), a cytoskele-
tal protein that is a well-established marker of differentiated
neurons within the central nervous system (Katsetos et al., 2003).
Transduction by LV-Runx1 particles increased the percentage of
Tuj1 + cells from 2.2% of cells in control LV-GFP cultures to 32.9%
(Fig. 6B). These data show that over-expression of Runx1 in
neurosphere cultures promoted the differentiation of neuronal
precursor cells and differentiated neurons in a signiﬁcant percent-
age of NSPCs.
To determine whether there was any change in astrocytic differ-
entiation, we also examined the expression of S100β, an astrocytic
marker that is not expressed in adult NSPCs (Bernal & Peterson,
2011; Raponi et al., 2007). LV-GFP-transduced cultures exhibited
signiﬁcant expression of S100β, with 24.4% of cells expressing this
marker, showing that a quarter of the cells within the neurospheres
have already differentiated along the astrocyte lineage under our
culture conditions. Over-expression of Runx1 through LV-Runx1
transduction increased by 11%, the number of cells expressing
S100β to 35. 3% (Fig. 6D). Thus, Runx1 over-expression resulted in
an overall differentiation of the NSPCs, along both astrocytic andneuronal lineages, but with amore signiﬁcant promotion of neuronal
differentiation. Interestingly, this differentiation was not accompa-
nied by decreased proliferation.
4. Discussion
The induction of Runx1 in a subpopulation of putative adult NSPCs in
the SVZ and hippocampus following traumatic brain injury provided the
rationale for examining the function of Runx1 in NSPCs in neurosphere
culture (Logan et al., 2013). The data we present here indicate that
Runx1 could be regulating the post-injury proliferative or neuronal differ-
entiation response in these cells. We demonstrate that endogenous
Runx1 expression is highest in proliferating NSPCs in vitro, that it drops
on mitogen removal, and that NSPC proliferation is reduced upon
Runx1 inhibition. Runx1 expression is further depressed when cells are
stimulated to undergo astrocytic differentiation. Runx1 over-expression
produced a dramatic morphological change in the neurosphere cultures,
causing many cells to acquire a shape reminiscent of immature neurons
or neuroblasts. This morphological change was accompanied by a large
increase in the expression of the neuronal proteins DCX and Tuj1, with
a much smaller increase in the expression of the astrocytic protein
Fig. 6.Runx1 over-expression strongly increases Tuj1 expression, aswell as increasingDCX and S100β expression. Flow cytometry analysis indicates expression of different cell-speciﬁcmarkers
in lentiviral transduced neurosphere cultures. Histograms depict the distribution of cells expressing A) DCX, B) Tuj1, C) S100β transduced for 5 dayswith either LV-GFP (gray lines) or LV-
Runx1 (blue lines). The black bars in the graphs indicate the cell populations with strong antigen staining. D) The percentages of cells in the neurosphere culture expressing cell-speciﬁc
markers in each lentiviral-transduced population.
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liferation in cultured adult neurospheres, and promoting a pro-neuronal
fate choice on cell differentiation. This model is summarized in Fig. 7.Fig. 7.Model of the effects of various treatments on the proliferation rates and differentiation of cultu
protein expression and, concurrently, decreases neurosphere proliferation. Inhibition of Runx1
absence of bFGF further decreases Runx1 protein expression and induces neurosphere cultu
Runx1 causes a large percentage of cells to differentiate into neuronal cells, without affecting cWedemonstrate that removing bFGF from themedia causes a signif-
icant drop in Runx1 protein but not mRNA expression (Fig. 1). There is
signiﬁcant evidence for post-transcriptional regulation of Runx1 proteinred neurospheres. Removal of bFGF from growthmedia causes a drop in endogenous Runx1
activity with Ro5-3335 also decreases NSPC proliferation. Treatment with 1% FBS in the
res to differentiate almost entirely into astrocytes. Over-expression of Runx1 with LV-
ell proliferation.
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ed by the ubiquitin proteasome pathway, suggesting that any endoge-
nous modiﬁcation of the interaction with these two proteins could
potentially evoke an increase in Runx1 degradation rates (Huang et
al., 2001). The Cdk4/cyclin D1 complex can phosphorylate Runx1 and
target it for ubiquitination and degradation (Biggs et al., 2006). Addi-
tionally, extracellular signal-related kinase (ERK) can also phosphory-
late Runx1 at multiple sites, disrupting the interaction between Runx1
and its corepressor protein mSin3A, and thereby facilitating the proteo-
lytic degradation of Runx1 (Imai et al., 2004). Finally Runx1 mRNA is
targeted by severalmiRNAs allowing for signiﬁcant post-transcriptional
regulation of Runx1 protein expression (Fischer et al., 2015; Miao et al.,
2015; Rossetti & Sacchi, 2013; Bernardin-Fried, 2004). It is not clear if
bFGF signaling potentially maintains Runx1 protein expression through
increased translation by regulation of speciﬁc miRNAs, or if removal of
bFGF signaling leads to increased Runx1degradation andhence a reduc-
tion in Runx1 protein levels. As bFGF is a pro-mitotic factor for cultured
NSPCs (Kuhnet al., 1997; Vescovi et al., 1993;Wagner et al., 1999), bFGF
signaling links Runx1 levels and neurosphere proliferation.
Runx1 expression was further decreased upon addition of 1% FBS, a
treatment that induces nearly exclusive astrocytic differentiation (Fig.
1). In these neurosphere growth conditions, there was a non-signiﬁcant
decrease in Runx1 mRNA expression suggesting that the decrease in
Runx1 protein could bemediated by transcriptional and post-transcrip-
tional mechanisms. Together, these data indicate that Runx1 is
expressed highest in neurosphere cells that are in an undifferentiated,
highly proliferative state. As NSPCs are stimulated to undergo astrocytic
differentiation, there is a concomitant decrease of Runx1 expression,
possibly as part of an overall down-regulation of pro-neuronal differen-
tiation pathways. Theseﬁndings are in agreementwith Bonnert and col-
leagues (Bonnert et al., 2006), who found the highest Runx1 mRNA
expression in neurospheres in growth media. Runx1 mRNA expression
dropped upon stimulation of neurospheres to differentiate by either re-
moval of EGF and bFGF, or by treatment with FBS. They also found that
Runx1 mRNA expression was enriched in FACS-sorted cells isolated di-
rectly from the SVZ that were selected for their high expression of pro-
liferative markers (Bonnert et al., 2006).
Inhibition of endogenous Runx1 activity with Ro5-3335 led to a de-
crease in neurosphere size as well as the percentage of cells incorporat-
ing EdU (Fig. 2). Thus, inhibition of Runx1 results in decreased NSPC
proliferation, suggesting that endogenous Runx1 protein expressed in
neurosphere cultures is necessary to maintain normal levels of cell divi-
sion in growthmedia. This is in agreement with the ﬁnding that inhibi-
tion of Runx1 in Ba/F3 cells slows the G1 to S progression of the cell
cycle (Bernardin-Fried, 2004). Although Ro5-3335has not been demon-
strated to affect any other pathways known to regulate NSPC prolifera-
tion, we cannot exclude the possibility of potential non-speciﬁc effects
of the compound that are unrelated to Runx1 signaling. However, sup-
port for Ro5-3335 inhibition of Runx1 activity is provided by a similar
reduction in NPSC proliferation with Runx1 knockdown by lentiviral
expressed shRNA against Runx1 (Fig. 4). Inhibition of Runx1 activity
with Ro5-3335 also increased the expression of p21 and cyclin D1
mRNA. Both of these genes are immediate downstream targets of
Runx1 regulation (Theriault et al., 2005; Robertson et al., 2008). p21 is
directly repressed by Runx1 in mouse embryonic cortical progenitor
cells (Theriault et al., 2005), and when induced, is able to inhibit prolif-
eration of many cells (Cazzalini et al., 2010). The cyclin D1 gene
(CCND1) is also a direct transcriptional target of Runx1, but inhibition
of Runx1 inhibits CCND1 expression (Muller-Tidow et al., 2004;
Voronov et al., 2013). Therefore, the effect of Ro5-3335 on CCND1 ex-
pression is unexpected and may be through an indirect mechanism.
Transcriptional regulation by Runx1 is highly context dependent:
Runx1 can either activate or repress gene transcription in different cel-
lular contexts (Stifani &Ma, 2009). Cyclin D1 induction is typically asso-
ciatedwith increased cell proliferation as it usually acts as a promoter of
mitosis. However, this is not universal, and Cyclin D1 is sometimesincreased in instances of growth inhibition (Pineda et al., 2013). Indeed,
in neurospheres cultured from adult mice, TGF-ß1 induced expression
of both Cyclin D1 and P21 proteins, concurrent with a potent inhibition
of neurosphere proliferation (Pineda et al., 2013). Thus, co-induction of
p21 and cyclin D1 may be a common mechanism of inhibition of
neurosphere proliferation.
Over-expression of Runx1 did not lead to any alteration in the prolif-
eration of neurosphere cells, despite a dramatic increase in differentia-
tion and morphology usually associated with post-mitotic cell
populations in vivo. Theriault and colleagues showed that Runx1 over-
expression in culture elevated expression of the proliferative marker
Ki67, together with NeuroD1, a typical marker of mature post-mitotic
neurons. They also found Runx1 to be expressed in NeuroD1-positive
cells that were proliferative in vivo (Theriault et al., 2005). Our data
that inhibition of Runx1 with Ro5-3335 inhibited NSPC proliferation
while over-expression of Runx1 did not alter proliferation suggest that
a threshold of Runx1 activity is necessary to support NSPC proliferation
in neurospheres in normal growthmedia. However, Runx1 does not ap-
pear to be a rate-limiting proliferative factor, as further increasing
Runx1 expression does not further elevate proliferation.
Neurosphere cultures contain a heterogeneous mixture of cells, in-
cluding self-renewing, tripotent stem cells, rapidly dividing intermedi-
ate progenitors, which can undergo a limited number of divisions
before differentiating into the neuronal or glial lineages, more restricted
glial or neuronal progenitor cells, as well as post-mitotic, differentiated
cells. These cultures additionally contain dead cells, which exist in the
core of the neurosphere colonies and have died due to the restricted
ﬂow of nutrients (Reynolds & Weiss, 1992; Gil-Perotin et al., 2013;
Ramasamy et al., 2013). In our proliferative neurospheres, we detected
a population of DCX+ neuronal progenitor cells (roughly 20%) as ex-
pected. Runx1 over-expression induced a small increase in the percent-
age of cells expressing DCX, suggesting that Runx1 can push stem cells
to develop into these DCX+ neuronal-restricted progenitors. Runx1
over-expression also induced a sizable population of cells expressing
high levels of Tuj1 (about a third of the total cell population), whereas
this cell population was virtually absent in cells transduced with a con-
trol lentivirus. Expression of Tuji1 corresponded with a distinct neuro-
nal-like morphological change. As we treated with LV-Runx1 for
5 days, it is possible that many of the stem cells progressed through
the DCX+ stage to the more differentiated TUJ1+, DCX− phenotype.
Thus, a shorter treatment may have resulted in a greater DCX+ transi-
tion. Our data show that Runx1 can act as a pro-neuronal differentiation
factor in adult NSPCs. There was also a slight increase in the expression
levels of S100β protein after LV-Runx1 treatment (Fig. 6). As S100β pro-
tein is unique to differentiated astrocytes and not expressed in NSPCs
(Bernal & Peterson, 2011; Raponi et al., 2007), our results indicate that
there is a basal level of astrocytic differentiation in neurosphere
cultures, and that Runx1 over-expression slightly increased this
occurrence.
Given the heterogeneous nature of the neurosphere cultures, the di-
vergent differentiation effects could bedue to the actions of Runx1 over-
expression in different cell populations within the neurosphere cul-
tures. Unfortunately, since the protein markers we were investigating
are all intracellular, the cells had to be ﬁxed and permeabilized in
order to perform the immunostaining necessary for ﬂow cytometry
quantiﬁcation. This led to a near-complete loss of the GFP protein as
an indicator of lentiviral transduction. As such, wewere unable to quan-
tify the percentages of cells expressing the differentiation markers spe-
ciﬁcally within cells deﬁnitively transduced by our lentiviral treatment
and were limited to quantifying changes within the entire cell popula-
tion. Thus, we cannot distinguish which effects were cell intrinsic and
which may be downstream effects of cell–cell signaling within the cul-
ture. Intercellular communication has a signiﬁcant impact on the behav-
ior andphenotype of adult neurosphere cultures, and differentiating cell
populations can induce other cells within the culture to differentiate as
well.
563T.T. Logan et al. / Stem Cell Research 15 (2015) 554–564Our experiments suggest that Runx1 may be a useful target to ma-
nipulate in order to direct the endogenous NSPC proliferative response
toward maximal neurogenesis following traumatic brain injury. Runx1
over-expression has been demonstrated to facilitate neuronal differen-
tiation and long-range axonal growth in cells derived from embryonic
human spinal cord and transplanted into adult rat dorsal root ganglia
(Konig et al., 2011). Our studies suggest the potential for a similar effect
when using neural stem cells isolated or induced from adult tissue.
Stimulation of Runx1 expression in neural stem cells may enable these
cells to maintain their neuronal potential when transplanted and
hence enhance the repair and repopulation of the damaged CNS.
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